Additionally, the APOE ε3 R136S (Christchurch) variant (APOE-Ch) has been found to protect against an EOAD PSEN1 mutation, delaying cognitive impairment and reducing tau pathology despite high levels of Aβ [28, 29]. This evidence concerns the gene APOE and Cognitive impairment.